Margin.
Pace.
Position.
The whole GTM playbook is being rewritten in real time, across every commercial team at once.
This briefing tells you how the GTM playbook gets rewritten in specialist research and intelligence as AI compresses every commercial team. Read it before your competitors hit their first AI-native quarter.
The 10-page briefing. Worth 20 minutes.
One email. One PDF. Worth twenty minutes of your week.
We send it once. Work emails only.
Every commercial director at a mid-market research firm in Europe has had the same Monday morning this year. The Q1 renewals call ran long. A three-year client wanted 20% less budget for the same scope. Their reason: the internal team is using AI for the first pass now. Your best senior analyst mentioned a call from a competitor on Friday.
You have done this job for fifteen years. The pattern used to be simple. Do good work. Publish credible research. Sit across from a CFO and make the case for twelve more months. Retention stayed above ninety. Something changed.
This is not a you problem. It is an industry problem and a function problem happening at the same time. Most research commercial directors are treating them as two. The ones who see them as one are going to own the next decade of specialist intelligence work.
Same eighteen months. Same accumulated work behind you. Opposite outcomes. The difference is the operator, not the AI.
Your CEO is already asking you about this. The briefing below is what you want in your hand before that conversation.
Renewals. What comes next. The asset underneath.
Three questions every research commercial director is tracking. None of them used to be the same question. They are now.
Why are we losing renewals we used to hold?
Your three-year client asked for 20% less budget. Their team uses an internal AI tool now. Your account director did not have a defence because the defence is not on price. The conversation used to be about relationship and scope. It is now about what the client's own team cannot produce.
What will our clients actually pay for in 2027?
The deliverable the client can now produce in a morning is not the product. The contrarian reading backed by twenty years of sector pattern recognition is. Your proposals still describe deliverables. The advisory pipeline is flat because the pitch sounds like a research output to a client who no longer buys research outputs.
What are we doing with twenty years of client work?
Your firm has two decades of sector files, methodology records, benchmark data, and analyst judgment sitting in shared drives. The AI-native entrant does not. This is the asset that survives the commoditisation of production. Nobody on your commercial team is currently paid to turn it into a product.
What you get when you download
An 11-page report for commercial directors at mid-market specialist research and intelligence firms. Designed to be read in one sitting before your next leadership team meeting.
Your industry, your function, and why they are one problem
What is happening in specialist research as a sector. What is happening to your renewals book and your proposal pipeline right now. And the intersection most commercial directors have not named yet. Plain language you can use in the boardroom.
Four moves across sales, marketing, research, and pricing
How to change the renewals conversation from scope to access. How to shift marketing from publication calendar to authority engine. How to turn twenty years of client work into a queryable asset. How to migrate pricing from information delivery to insight advisory.
Five questions for your next leadership team meeting
Last ten renewals that shrank or paused. Proposal language describing a deliverable vs describing an insight. Top-three senior analyst succession. Twenty years of files in shared drives. The analysts already doing what the rest of the bench will need to do by 2027. Ask these honestly.
Calibrated for each seat at the table.